Merck Insomnia Drug Safe Only in Low Doses

May 23 (Bloomberg) -- Merck & Co.’s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi’s Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Full Show: What'd You Miss? (04/28)
23:00 - Guests include: Billionaire environmental activist Tom Steyer, Cuemacro founder Saeed Amen, Ballard Spahr's Dee Spagnuolo and Meghan Duggan, captain of the U.S. Women's National Hockey team. (Source: Bloomberg)
  • How Virtual Reality Is Impacting Storytelling
  • Quants Fire Back at Paul Tudor Jones
  • Full Show: Bloomberg Best (04/28)